Allergies to cats are the most common animal-origin allergies in humans1 and affect approximately 1 in 5 adults worldwide.2
Cat owners may be encouraged to avoid contact with their cat on an allergist’s recommendation, but often go to great lengths to keep their cat. At the very least, they may be forced to spend less time with their cat. They will often have to exclude their cat from the bedroom and take medications to try to manage their allergic symptoms.
Cat allergies can also be a barrier to cat ownership by preventing adoption and potentially leading to cat rehoming or relinquishment.3-6 This is why Purina scientists have dedicated more than 10 years to researching how to manage cat allergens and improve the lives of cat lovers and their feline companions.
Purina scientists discovered that an egg product ingredient containing antibodies to Fel d1, the major cat allergen, can bind to Fel d1 in the cat’s saliva, preventing its ability to trigger an allergic response in a cat allergen-sensitized individual.
This discovery may lead to novel and exciting approaches for managing cat allergens, while maintaining the normal production of Fel d1 by the cat and without impacting the cat’s overall physiology. These breakthrough findings can transform how people manage allergies to cats while keeping the cat in the home.